• 1. Department of Radiology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China;
  • 2. Mallinckrodt Radiological Institute in Washington University, Washington DC 63110, America;
SONGBin, Email: cjr.songbin@vip.163.com
Export PDF Favorites Scan Get Citation

Objective To explore the utility of magnetic resonance-T1ρ-weighted imaging (T1ρWI) in the diagnosis of human primary hepatic carcinoma. Methods Nine patients were prospectively collected from West China Hospital of Sichuan University during January 2014 and June 2014, who had liver lesion that identified by the ultrasound or CT examination, and then were verified as primary hepatic carcinoma with pathological biopsy. A routine T2WI, pre-and post-contrast T1WI, pre-and post-contrast T1ρWI were performed on a 3.0 T clinical imager. The tumor-to-normal-tissue contrast was compared between pre-contrast T1ρWI/post-contrast T1ρWI and other sequences respectively, to investigate the value of T1ρWI in the diagnosis of human primary hepatic carcinoma. Results The tumor-to-normal-tissue contrast of pre-and post-contrast T1WI were lower than that of pre-contrast T1ρWI (t=3.532, P=0.008; t=3.666, P=0.006), while there was no statistical difference between T2WI and pre-contrast T1ρWI (t=-1.448, P=0.186). And compared with post-contrast T1ρWI, post-contrast T1WI had lower tumor-to-normal-tissue contrast (t=3.468, P=0.008). Conclusions T1ρWI can provide a better image of human primary hepatic carcinoma, thus T1ρWI is expected to become a new and useful method in MR scanning. It also shows potential value who can be used as an artery imaging that without using contrast agents.

Citation: ZHENGXing-ju, ZHENGJie, SUNJia-yu, WUBing, GAOFa-bao, SONGBin. Preliminary Utility of Magnetic Resonance-T1ρ-Weighted Imaging in The Diagnosis of Human Primary Hepatic Carcinoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2015, 22(6): 743-745. doi: 10.7507/1007-9424.20150194 Copy

  • Previous Article

    关于乳腺癌根治术后局部复发的一点思考(附1例报道)
  • Next Article

    Research Progress of The Monocarboxylate Transporter Proteins in Malignant Tumors